help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mukaetova-Ladinska, E. B.
Right arrow Articles by Wischik, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mukaetova-Ladinska, E. B.
Right arrow Articles by Wischik, C. M.

American Journal of Pathology, Vol 143, 565-578, Copyright © 1993 by American Society for Investigative Pathology


REGULAR ARTICLES

Biochemical and anatomical redistribution of tau protein in Alzheimer's disease

EB Mukaetova-Ladinska, CR Harrington, M Roth and CM Wischik
Cambridge Brain Bank Laboratory, University of Cambridge Department of Psychiatry, England.

We have developed assays that distinguish tau protein incorporated into the core structure of the paired helical filament (PHF) from non-PHF tau protein in brain tissue, whether soluble or insoluble. The PHF content was 19-fold greater in Alzheimer's disease cases compared with cognitively intact controls, and in temporal cortex the difference was 40-fold. There was a threefold decrease in soluble tau protein in Alzheimer's disease cases compared with normal age-matched controls, the decrease being greatest in frontal cortex. The PHF content was closely correlated with the number of tau-immunoreactive dystrophic neurites in plaques and throughout the neuropil, whereas counts of neurofibrillary tangles were poorer predictors of PHF content. beta- Amyloid deposits correlated neither with PHF content nor with neurofibrillary pathology. These findings suggest that Alzheimer's disease is characterized by a substantial redistribution of available tau protein from free to PHF-incorporated fractions and that PHF accumulation may be important in neurites as well as tangles in predicting the extent of cognitive impairment in Alzheimer's disease.


This article has been cited by other articles:


Home page
Physiol. Rev.Home page
J. AVILA, J. J. LUCAS, M. PEREZ, and F. HERNANDEZ
Role of Tau Protein in Both Physiological and Pathological Conditions
Physiol Rev, April 1, 2004; 84(2): 361 - 384.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
E. B. Mukaetova-Ladinska, F. Garcia-Siera, J. Hurt, H. J. Gertz, J. H. Xuereb, R. Hills, C. Brayne, F. A. Huppert, E. S. Paykel, M. McGee, et al.
Staging of Cytoskeletal and {beta}-Amyloid Changes in Human Isocortex Reveals Biphasic Synaptic Protein Response during Progression of Alzheimer's Disease
Am. J. Pathol., August 1, 2000; 157(2): 623 - 636.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
N.H.P. Allen and A. Burns
The treatment of Alzheimer's disease
J Psychopharmacol, January 1, 1995; 9(1): 43 - 56.
[PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by the American Society for Investigative Pathology.